Key points are not available for this paper at this time.
This Viewpoint characterizes incidental radiographic findings from clinical trial–related imaging as an underrecognized potential harm of trial participation and proposes practices and standards to more systematically include them as a trial safety end point.
Oren et al. (Mon,) studied this question.